Laurikainen E, Arstila M, Pekkarinen A, Kanto J
Int J Clin Pharmacol Ther Toxicol. 1985 Jan;23(1):16-9.
Lidocaine dosage recommendations vary widely. Severe heart failure adds to risk factors when attempting to reach the optimal therapeutic blood level. Fifty-two coronary care unit (CCU) patients, who were treated with lidocaine infusion after an initial bolus injection of 100 mg, were randomly selected for the study. Blood samples were drawn at 2, 6 and 18 h. The material was divided into four groups according to infusion rates: Group A (n = 15) 4 mg/min for 3 h and then 3 mg/min for 15 h, Group B (n = 10) 4 mg/min for 3 h and then 2 mg/min for 15 h, Group C (n = 9) 2 mg/min for 18 h and Group D (n = 18) according to clinical situation by a mean rate of 3.3 mg/min for 2 h, 2.5 mg/min for 4 h and 2.15 mg/min for 12 h. The mean serum lidocaine concentrations were in optimum therapeutic range of 2-4 mg/l in Groups A, B and D at every sampling time point. Percentage of the patients whose lidocaine concentrations at each sampling time were within the optimum range as follows: Group A 72, 67 and 52, Group B 70, 70 and 56%, Group C 0, 38 and 63% and Group D 38, 38 and 30%. Our material indicates that the optimal lidocaine infusion rate for CCU patients should be as in Group B.
利多卡因的剂量推荐差异很大。在试图达到最佳治疗血药浓度时,严重心力衰竭会增加风险因素。52名冠心病监护病房(CCU)患者在初始静脉推注100毫克利多卡因后接受利多卡因输注治疗,被随机选入该研究。在2小时、6小时和18小时采集血样。根据输注速率将材料分为四组:A组(n = 15),以4毫克/分钟的速率输注3小时,然后以3毫克/分钟的速率输注15小时;B组(n = 10),以4毫克/分钟的速率输注3小时,然后以2毫克/分钟的速率输注15小时;C组(n = 9),以2毫克/分钟的速率输注18小时;D组(n = 18),根据临床情况,平均速率为3.3毫克/分钟输注2小时,2.5毫克/分钟输注4小时,2.15毫克/分钟输注12小时。在每个采样时间点,A组、B组和D组的平均血清利多卡因浓度处于2 - 4毫克/升的最佳治疗范围内。每个采样时间利多卡因浓度处于最佳范围内的患者百分比如下:A组为72%、67%和52%,B组为70%、70%和56%,C组为0%、38%和63%,D组为38%、38%和30%。我们的材料表明,CCU患者的最佳利多卡因输注速率应为B组的速率。